Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
Yashpal Singh Rawat, Vice President and Facility Director at Fortis Healthcare, shared on LinkedIn:
”Fortis Memorial Research Institute made its positive mark at ASH in USA !
It is a moment of immense pride for all of us at Fortis Memorial Research Institute, Gurugram to witness our institution represented on the global stage at the American Society of Hematology (ASH) 2025 Annual Meeting in Orlando, USA- the most prestigious and influential conference in the field of hematology.
Dr. Rahul Bhargava’s podium oral presentation on “Dissecting India’s Molecular Hematology Landscape: A 1000-patient genomic study” marks not just a scientific achievement but a defining milestone for FMRI.
Taking FMRI’s research from Gurugram to an international platform of this calibre reflects the depth, rigor, and innovation of the work being done here.
This recognition is a testament to the dedication of the entire molecular hematology team-the scientists, clinicians, technologists, and collaborators whose relentless efforts made this study possible.
Your commitment to advancing genomic medicine in India has now been acknowledged at the highest level in global hematology.
Congratulations to Dr. Rahul Bhargava for representing FMRI with excellence, and kudos to every team member who contributed to this landmark achievement.
This is just the beginning, and we look forward to many more such accomplishments that continue to position FMRI as a leader in cutting-edge hematology research.
Proud moment for FMRI.
Proud moment for Fortis Family.”
All from ASH25 featured in Hemostasis Today.
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment
-
Jun 26, 2026, 13:25Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region